HLA-C and neoplasm: In this scenario, the downregulation of MHC-I in tumors helps tumor cells to escape surveillance of αβ T cells, but it does not inhibit non-MHC-restrict γδ T cell activation and even enhances the consecutive γδ T cell activation (128).